NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2

Oncotarget

Volumn 6, Issue 32, 2015, Pages 32410-32425

  Hu, Pengnan ^a   Chu, Junjun ^a   Wu, Yanqing ^a   Sun, Lijuan ^a   Lv, Xiaobin ^a   Zhu, Yinghua ^a   Li, Jingjing ^a   Guo, Qiannan ^a   Gong, Chang ^a   Liu, Bodu ^a   Su, Shicheng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Breast cancer; LncRNA; Metastasis; NBAT1

Indexed keywords

DICKKOPF 1 PROTEIN; LONG UNTRANSLATED RNA; LONG UNTRANSLATED RNA NBAT1; POLYCOMB REPRESSIVE COMPLEX 2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; DKK1 PROTEIN, HUMAN; EZH2 PROTEIN, HUMAN; NBAT1 LONG NONCODING RNA, HUMAN; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR EZH2; TUMOR MARKER;

ARTICLE; BREAST METASTASIS; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; UPREGULATION; WNT SIGNALING PATHWAY; BREAST TUMOR; CELL MOTION; ENZYMOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETIC TRANSFECTION; GENETICS; KAPLAN MEIER METHOD; MCF-7 CELL LINE; METABOLISM; MORTALITY; PATHOLOGY; PROCEDURES; PROGNOSIS; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTOR; TUMOR INVASION;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; CELL MOVEMENT; ENHANCER OF ZESTE HOMOLOG 2 PROTEIN; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIER ESTIMATE; MCF-7 CELLS; NEOPLASM INVASIVENESS; POLYCOMB REPRESSIVE COMPLEX 2; PROGNOSIS; PROTEIN INTERACTION MAPS; RNA INTERFERENCE; RNA, LONG NONCODING; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 84946084642     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5609     Document Type: Article

References (38)

1. Gibb EA, Brown CJ and Lam WL. The functional role of long non-coding RNA in human carcinomas. Molecular cancer. 2011; 10:38.
2. Matouk IJ, Raveh E, Abu-Lail R, Mezan S, Gilon M, Gershtain E, Birman T, Gallula J, Schneider T, Barkali M, Richler C, Fellig Y, Sorin V, Hubert A, Hochberg A and Czerniak A. Oncofetal H19 RNA promotes tumor metastasis. Biochimica et biophysica acta. 2014; 1843:1414-1426.
3. Gumireddy K, Li A, Yan J, Setoyama T, Johannes GJ, Orom UA, Tchou J, Liu Q, Zhang L, Speicher DW, Calin GA and Huang Q. Identification of a long non-coding RNA-associated RNP complex regulating metastasis at the translational step. The EMBO journal. 2013; 32:2672-2684.
4. Liu B, Sun L, Liu Q, Gong C, Yao Y, Lv X, Lin L, Yao H, Su F, Li D, Zeng M and Song E. A Cytoplasmic NFkappaB Interacting Long Noncoding RNA Blocks IkappaB Phosphorylation and Suppresses Breast Cancer Metastasis. Cancer cell. 2015; 27:370-381.
5. Zhao J, Sun BK, Erwin JA, Song JJ and Lee JT. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science. 2008; 322:750-756.
6. Zhang J, Zhang P, Wang L, Piao HL and Ma L. Long noncoding RNA HOTAIR in carcinogenesis and metastasis. Acta biochimica et biophysica Sinica. 2014; 46:1-5.
7. Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, Sabel MS, Livant D, Weiss SJ, Rubin MA and Chinnaiyan AM. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100:11606-11611.
8. Collett K, Eide GE, Arnes J, Stefansson IM, Eide J, Braaten A, Aas T, Otte AP and Akslen LA. Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2006; 12:1168-1174.
9. Wang C, Liu Z, Woo CW, Li Z, Wang L, Wei JS, Marquez VE, Bates SE, Jin Q, Khan J, Ge K and Thiele CJ. EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR. Cancer research. 2012; 72:315-324.
10. Pandey GK, Mitra S, Subhash S, Hertwig F, Kanduri M, Mishra K, Fransson S, Ganeshram A, Mondal T, Bandaru S, Ostensson M, Akyurek LM, Abrahamsson J, Pfeifer S, Larsson E, Shi L, et al. The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation. Cancer cell. 2014; 26:722-737.
11. Pandey GK and Kanduri C. Fighting Neuroblastomas with NBAT1. Oncoscience. 2015; 2:79-80.
12. Park C, Yu N, Choi I, Kim W and Lee S. lncRNAtor: a comprehensive resource for functional investigation of long non-coding RNAs. Bioinformatics. 2014; 30:2480-2485.
13. Kanduri M, Sander B, Ntoufa S, Papakonstantinou N, Sutton LA, Stamatopoulos K, Kanduri C and Rosenquist R. A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma. Epigenetics: official journal of the DNA Methylation Society. 2013; 8:1280-1288.
14. Welstead GG, Creyghton MP, Bilodeau S, Cheng AW, Markoulaki S, Young RA and Jaenisch R. X-linked H3K27me3 demethylase Utx is required for embryonic development in a sex-specific manner. Proceedings of the National Academy of Sciences of the United States of America. 2012; 109:13004-13009.
15. Cui P, Liu W, Zhao Y, Lin Q, Zhang D, Ding F, Xin C, Zhang Z, Song S, Sun F, Yu J and Hu S. Comparative analyses of H3K4 and H3K27 trimethylations between the mouse cerebrum and testis. Genomics, proteomics & bioinformatics. 2012; 10:82-93.
16. Bachmann IM, Halvorsen OJ, Collett K, Stefansson IM, Straume O, Haukaas SA, Salvesen HB, Otte AP and Akslen LA. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2006; 24:268-273.
17. Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani RS, Tomlins SA, Mehra R, Laxman B, Cao X, Yu J, Kleer CG, Varambally S and Chinnaiyan AM. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene. 2008; 27:7274-7284.
18. Yu H, Simons DL, Segall I, Carcamo-Cavazos V, Schwartz EJ, Yan N, Zuckerman NS, Dirbas FM, Johnson DL, Holmes SP and Lee PP. PRC2/EED-EZH2 complex is upregulated in breast cancer lymph node metastasis compared to primary tumor and correlates with tumor proliferation in situ. PloS one. 2012; 7:e51239.
19. Baillo A, Giroux C and Ethier SP. Knock-down of amphiregulin inhibits cellular invasion in inflammatory breast cancer. Journal of cellular physiology. 2011; 226:2691-2701.
20. Cowling VH and Cole MD. Turning the tables: Myc activates Wnt in breast cancer. Cell cycle. 2007; 6:2625-2627.
21. Cowling VH, D'Cruz CM, Chodosh LA and Cole MD. c-Myc transforms human mammary epithelial cells through repression of the Wnt inhibitors DKK1 and SFRP1. Molecular and cellular biology. 2007; 27:5135-5146.
22. Fillmore RA, Mitra A, Xi Y, Ju J, Scammell J, Shevde LA and Samant RS. Nmi (N-Myc interactor) inhibits Wnt/betacatenin signaling and retards tumor growth. International journal of cancer Journal international du cancer. 2009; 125:556-564.
23. Menezes ME, Mitra A, Shevde LA and Samant RS. DNAJB6 governs a novel regulatory loop determining Wnt/beta-catenin signalling activity. The Biochemical journal. 2012; 444:573-580.
24. Sato N, Yamabuki T, Takano A, Koinuma J, Aragaki M, Masuda K, Ishikawa N, Kohno N, Ito H, Miyamoto M, Nakayama H, Miyagi Y, Tsuchiya E, Kondo S, Nakamura Y and Daigo Y. Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy. Cancer research. 2010; 70:5326-5336.
25. Xu WH, Liu ZB, Yang C, Qin W and Shao ZM. Expression of dickkopf-1 and beta-catenin related to the prognosis of breast cancer patients with triple negative phenotype. PloS one. 2012; 7:e37624.
26. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A and Weinberg RA. An embryonic stem celllike gene expression signature in poorly differentiated aggressive human tumors. Nature genetics. 2008; 40:499-507.
27. Kaneko S, Li G, Son J, Xu CF, Margueron R, Neubert TA and Reinberg D. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes & development. 2010; 24:2615-2620.
28. Maenner S, Blaud M, Fouillen L, Savoye A, Marchand V, Dubois A, Sanglier-Cianferani S, Van Dorsselaer A, Clerc P, Avner P, Visvikis A and Branlant C. 2-D structure of the A region of Xist RNA and its implication for PRC2 association. PLoS biology. 2010; 8:e1000276.
29. Kanhere A, Viiri K, Araujo CC, Rasaiyaah J, Bouwman RD, Whyte WA, Pereira CF, Brookes E, Walker K, Bell GW, Pombo A, Fisher AG, Young RA and Jenner RG. Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2. Molecular cell. 2010; 38:675-688.
30. Chu C, Qu K, Zhong FL, Artandi SE and Chang HY. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Molecular cell. 2011; 44:667-678.
31. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and Chang HY. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007; 129:1311-1323.
32. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, Li R, West RB, van de Vijver MJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010; 464:1071-1076.
33. Hussein YR, Sood AK, Bandyopadhyay S, Albashiti B, Semaan A, Nahleh Z, Roh J, Han HD, Lopez-Berestein G and Ali-Fehmi R. Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer. Human pathology. 2012; 43:1638-1644.
34. Chisholm KM, Wan Y, Li R, Montgomery KD, Chang HY and West RB. Detection of long non-coding RNA in archival tissue: correlation with polycomb protein expression in primary and metastatic breast carcinoma. PloS one. 2012; 7:e47998.
35. Wu Y, Zhang L, Zhang L, Wang Y, Li H, Ren X, Wei F, Yu W, Liu T, Wang X, Zhou X, Yu J and Hao X. Long noncoding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma. International journal of oncology. 2015; 46:2586-94.
36. Holm K, Grabau D, Lovgren K, Aradottir S, GruvbergerSaal S, Howlin J, Saal LH, Ethier SP, Bendahl PO, Stal O, Malmstrom P, Ferno M, Ryden L, Hegardt C, Borg A and Ringner M. Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes. Molecular oncology. 2012; 6:494-506.
37. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC and Weinberg RA. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes & development. 2001; 15:50-65.
38. Band V, Zajchowski D, Kulesa V and Sager R. Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proceedings of the National Academy of Sciences of the United States of America. 1990; 87:463-467.